CDB Global Sciences Inc., Provides Update on Covid-19 and Announces Reliance upon Interim and Annual Financial Statements and MD&A Filing Exemption

April 29, 2020

22nd Century Group (XXII) Highlights Recent TCORS Symposium Findings

May 25, 2023
Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately Euro32M, or 70%, by the End of 2025 vs FY 2022.

May 25, 2023
Item 9 Labs Corp. Executes Major Restructuring to Pave the Way to Profitability

May 23, 2023
LiveWire Ergogenics Reports First Quarter 2023 Financial Results Generates Fifth Consecutive Profitable Quarter

May 19, 2023